Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone acetonide plus laser vs bevacizumab plus laser vs laser alone for diffuse non-tractional diabetic macular edema
2009-014654-15Phase 4Active
- Sponsor
- Alicia Pareja RÃos
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of triamcinolone acetonide and bevacizumab in diabetic macular edema (DME) (3 arms), sponsored by Alicia Pareja RÃos. Primary endpoints: Best corrected visual acuity change from baseline and Post-treatment best corrected visual acuity. Started Jan 2010; status: active.
02
Drugs
triamcinolone acetonidebevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2009-014654-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014654-15.